Pierre Fabre loses chief executive

pharmafile | February 11, 2011 | Appointment | Sales and Marketing |  Olivier Bohuon, Pierre Fabre, Smith & Nephew, appointment, medical devices, sales and marketing 

Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive.

He will officially move to Smith & Nephew in April, heading up the medical devices company as chief executive and taking over from Dave Illingworth who retires later this year.

Smith & Nephew chairman John Buchanan said: “Our board is, of course, very sorry that Dave has decided to retire. In his nine years with Smith & Nephew Dave has made a major impact, with various distinctive achievements.

Advertisement

“At the same time we are delighted to have someone of Olivier Bohuon’s calibre to join us as chief executive. His global experience in healthcare makes him highly qualified to take the company forward, building on the strong momentum of the group.”

Prior to his stint at Pierre Fabre, Olivier served as executive vice-president of Abbott Corporation and was president of its pharmaceutical division.

Before Abbott he spent over 10 years at GlaxoSmithKline, ultimately as senior VP for European commercial operations – pharmaceuticals.

Related Content

Pierre Fabre partners with Know Your Lemons Foundation for breast cancer awareness

The campaign focuses on early detection and education Pierre Fabre Laboratories has announced a partnership …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

FDA approves Abbott’s Assert-IQ insertable cardiac monitor

Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance …

The Gateway to Local Adoption Series

Latest content